Loading...
AdAlta Limited
1AD.AX•ASX
Healthcare
Biotechnology
A$0.002
A$0.00(0.00%)
AdAlta Limited (1AD.AX) Financial Performance & Income Statement Overview
Review AdAlta Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-49.91%
↓ 49.91%
Operating Income Growth
36.91%
↑ 36.91%
Net Income Growth
-10.93%
↓ 10.93%
Operating Cash Flow Growth
-2.49%
↓ 2.49%
Operating Margin
-492.79%
↓ 492.79%
Gross Margin
78.23%
↑ 78.23%
Net Profit Margin
-508.01%
↓ 508.01%
ROE
-464.18%
↓ 464.18%
ROIC
-291.51%
↓ 291.51%
AdAlta Limited (1AD.AX) Income Statement & Financial Overview
Review AdAlta Limited's (1AD.AX) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $597934.00 | $1.14M | $2.36M | $1.11M |
| Cost of Revenue | $112447.00 | $9978.00 | $14867.00 | $15055.00 |
| Gross Profit | $485487.00 | $1.13M | $2.34M | $1.09M |
| Gross Profit Ratio | $0.81 | $0.99 | $0.99 | $0.99 |
| R&D Expenses | $2.13M | $2.03M | $2.24M | $1.40M |
| SG&A Expenses | $677115.00 | $2.05M | $2.18M | $2.49M |
| Operating Expenses | $2.81M | $4.08M | $4.42M | $3.89M |
| Total Costs & Expenses | $2.92M | $4.09M | $4.44M | $3.90M |
| Interest Income | $13380.00 | $33345.00 | $34763.00 | $27807.00 |
| Interest Expense | $42046.00 | $72953.00 | $74106.00 | $49645.00 |
| Depreciation & Amortization | $11883.00 | $9978.00 | $14867.00 | $15055.00 |
| EBITDA | -$2.37M | -$2.94M | -$4.42M | -$2.78M |
| EBITDA Ratio | -$3.96 | -$3.58 | -$1.87 | -$3.51 |
| Operating Income | -$2.33M | -$4.09M | -$4.44M | -$3.90M |
| Operating Income Ratio | -$3.89 | -$3.58 | -$1.88 | -$3.52 |
| Other Income/Expenses (Net) | -$671637.00 | -$35995.00 | $18412.00 | $587704.00 |
| Income Before Tax | -$3.00M | -$4.12M | -$4.42M | -$3.32M |
| Income Before Tax Ratio | -$5.01 | -$3.62 | -$1.87 | -$2.99 |
| Income Tax Expense | -$631279.00 | -$1.11M | -$2.39M | -$495454.00 |
| Net Income | -$2.37M | -$3.01M | -$2.03M | -$2.82M |
| Net Income Ratio | -$3.96 | -$2.64 | -$0.86 | -$2.54 |
| EPS | -$0.004 | -$0.007 | -$0.006 | -$0.009 |
| Diluted EPS | -$0.004 | -$0.007 | -$0.006 | -$0.009 |
| Weighted Avg Shares Outstanding | $529.09M | $454.20M | $324.18M | $314.18M |
| Weighted Avg Shares Outstanding (Diluted) | $535.00M | $454.20M | $324.18M | $314.18M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan